.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fish and Richardson
Healthtrust
Cerilliant
Farmers Insurance
McKesson
AstraZeneca
Chubb
Moodys
Cipla

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,750,237

« Back to Dashboard

Which drugs does patent 6,750,237 protect, and when does it expire?


Patent 6,750,237 protects ZOMIG and is included in one NDA. There have been two Paragraph IV challenges on Zomig.

Protection for ZOMIG has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,750,237

Title: Pharmaceutical formulations containing zolmitriptan
Abstract:A pharmaceutical formulation of the 5HT1-agonist, zolmitriptan, for use in intranasal administration. The formulation is useful in treating migraine and related disorders.
Inventor(s): Dearn; Alan Roy (Ware, GB), Williamson; Sarah Louise (Ware, GB), Summers; Simon John (Ware, GB), Coomber; Trevor John (Ware, GB)
Assignee: AstraZeneca AB (London, GB)
Application Number:10/129,773
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
AstrazenecaZOMIGzolmitriptanSPRAY;NASAL021450-003Sep 16, 2013RXYesNo► Subscribe► SubscribeY► Subscribe
AstrazenecaZOMIGzolmitriptanSPRAY;NASAL021450-004Sep 30, 2003RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,750,237

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9928578Dec 03, 1999
PCT Information
PCT FiledNovember 28, 2000PCT Application Number:PCT/GB00/04528
PCT Publication Date:June 07, 2001PCT Publication Number: WO01/39772

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Teva
US Army
Fish and Richardson
Deloitte
Johnson and Johnson
Farmers Insurance
Cerilliant
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot